| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing nizatidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Nizatidine measurement |
Component |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Nizatidine poisoning |
Causative agent (attribute) |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Accidental nizatidine poisoning |
Causative agent (attribute) |
False |
Nizatidine (substance) |
Inferred relationship |
Some |
|
| Intentional nizatidine poisoning |
Causative agent (attribute) |
False |
Nizatidine (substance) |
Inferred relationship |
Some |
|
| intoxication par la nizatidine d'intention indéterminée |
Causative agent (attribute) |
False |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Nizatidine adverse reaction |
Causative agent (attribute) |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to nizatidine |
Causative agent (attribute) |
False |
Nizatidine (substance) |
Inferred relationship |
Some |
|
| Nizatidine overdose |
Causative agent (attribute) |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Accidental nizatidine overdose |
Causative agent (attribute) |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Intentional nizatidine overdose |
Causative agent (attribute) |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| surdose de nizatidine d'intention indéterminée |
Causative agent (attribute) |
False |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely nizatidine 150 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nizatidine (substance) |
Inferred relationship |
Some |
|
| Nizatidine 300 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nizatidine (substance) |
Inferred relationship |
Some |
|
| nizatidine 25 mg/mL, ampoule de 4 mL d'une solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nizatidine (substance) |
Inferred relationship |
Some |
|
| Nizatidine 75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nizatidine (substance) |
Inferred relationship |
Some |
|
| Accidental nizatidine poisoning |
Causative agent (attribute) |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Intentional nizatidine poisoning |
Causative agent (attribute) |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Nizatidine 15 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nizatidine (substance) |
Inferred relationship |
Some |
|
| Allergy to nizatidine |
Causative agent (attribute) |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely nizatidine 150 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely nizatidine 150 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Nizatidine 300 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Nizatidine 300 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Nizatidine 75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Nizatidine 75 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely nizatidine 150 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Nizatidine 300 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Nizatidine 75 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely nizatidine 100 milligram/4 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely nizatidine 100 milligram/4 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Nizatidine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing nizatidine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only nizatidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Nizatidine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Nizatidine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely nizatidine 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely nizatidine 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Nizatidine 15 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
| Nizatidine 15 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nizatidine (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]